https://it.marketscreener.com/quotazioni/azione/ALLOGENE-THERAPEUTICS-INC-46536033/attualita/Allogene-Therapeutics-Inc-presenta-i-dati-preclinici-sulle-tecnologie-Cloak-e-Dagger-di-nuova-gene-45239574/?utm_source=telegram&utm_medium=social&utm_campaign=share